Inicio>>Signaling Pathways>> Neuroscience>> GABA Receptor>>Tiagabine hydrochloride

Tiagabine hydrochloride (Synonyms: ABT-569)

Catalog No.GC17402

El clorhidrato de tiagabina es un inhibidor potente y selectivo de la recaptaciÓn de GABA, utilizado como agente anticonvulsivo, con IC50 de 67, 446 y 182 nM para la captaciÓn de [3H]GABA en sinaptosomas, neuronas y glÍa, respectivamente.

Products are for research use only. Not for human use. We do not sell to patients.

Tiagabine hydrochloride Chemical Structure

Cas No.: 145821-59-6

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
38,00 $
Disponible
10mg
33,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Tiagabine hydrochloride is a potent and selective GABA reuptake inhibitor, used as an anticonvulsant agent, with IC50s of 67, 446 and 182 nM for [3H]GABA uptake in Synaptosomes, Neurons and Glia, respectively[1].

References:
[1]. Braestrup C, et al. (R)-N-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid binds with high affinity to the brain gamma-aminobutyric acid uptake carrier. J Neurochem. 1990 Feb;54(2):639-47.
[2]. Sheehan, D.V., et al., An open-label study of tiagabine in panic disorder. Psychopharmacol Bull, 2007. 40(3): p. 32-40.
[3]. Henjum, S. and B. Hassel, High-affinity GABA uptake and GABA-metabolizing enzymes in pig forebrain white matter: a quantitative study. Neurochem Int, 2007. 50(2): p. 365-70.

Reseñas

Review for Tiagabine hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 10 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tiagabine hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.